US Broker Ratings

Enovis Corporation (ENOV) Stock Analysis: A Strong Buy Amidst 69.94% Potential Upside

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector specializing in medical devices, presents an enticing opportunity for investors looking for growth potential coupled..

BGM Group Ltd. (BGM): A Deep Dive into the Healthcare Sector’s Uncharted Waters Amidst a 56.9% Revenue Decline

BGM Group Ltd. (BGM), a dynamic player in China’s healthcare sector, is navigating the turbulent waters of the drug manufacturing industry. Specializing in both specialty and..

Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a 25.75% Upside Potential

Teladoc Health, Inc. (NYSE: TDOC), a key player in the healthcare sector, specializes in virtual healthcare services that span across general medical, mental health, and chronic..

Neogen Corporation (NEOG) Investor Outlook: Potential 12.49% Upside and Analyst Consensus

As an investor focused on the healthcare sector, Neogen Corporation (NEOG) presents an intriguing opportunity, particularly in the diagnostics and research industry. Headquartered in Lansing, Michigan,..

HUTCHMED (China) Limited (HCM): Investor Outlook on a Potential 68.92% Upside

HUTCHMED (China) Limited (HCM) is generating buzz in the investment community with its significant potential upside of nearly 69%. As a prominent player in the healthcare..

Select Medical Holdings Corp (SEM): Investor Outlook with a Potential 21.45% Upside

Select Medical Holdings Corporation (NYSE: SEM) is making waves in the healthcare sector, particularly in the medical care facilities industry. Headquartered in Mechanicsburg, Pennsylvania, this company..

Apogee Therapeutics, Inc. (APGE): Investor Outlook with a Promising 26% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE) is capturing investor attention with its robust pipeline of novel biologics targeting a range of inflammatory and immunology conditions. With its..

Clover Health Investments, Corp (CLOV) Stock Analysis: Revenue Growth Shines Amidst Valuation Challenges

Clover Health Investments, Corp. (NASDAQ: CLOV), a player in the Healthcare Plans industry, is garnering attention due to its impressive revenue growth, yet investors must weigh..

Immunovant, Inc. (IMVT) Stock Analysis: A Bold 57% Upside Potential Beckons Investors

Immunovant, Inc. (NASDAQ: IMVT) is capturing investor attention with its compelling growth narrative and substantial upside potential. This clinical-stage biotechnology company, specializing in the development of..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: Unveiling a 52.88% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is capturing the attention of investors in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $2.8..

IDEAYA Biosciences, Inc. (IDYA) Investor Outlook: A 42% Potential Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine, focusing on innovative cancer therapies that leverage molecular diagnostics. The company’s strong positioning in..

Veracyte, Inc. (VCYT) Investor Outlook: Exploring a 10.47% Upside in the Diagnostics Sector

For investors with a keen eye on the healthcare sector, Veracyte, Inc. (NASDAQ: VCYT) emerges as a strong contender worth close attention. With its focus on..

SS Innovations International (SSII): Exploring the 192.50% Revenue Growth of a Rising Healthcare Player

SS Innovations International Inc. (SSII) is carving a niche for itself in the burgeoning healthcare sector, specifically within the medical devices industry. Headquartered in Gurugram, India,..

Immunocore Holdings plc (IMCR) Stock Analysis: A 95% Potential Upside with Breakthrough Immunotherapies

Immunocore Holdings plc (NASDAQ: IMCR) stands as a beacon in the biotechnology industry, leveraging its innovative approach to immunotherapies for combating cancer, infectious, and autoimmune diseases...

CONMED Corporation (CNMD) Stock Analysis: Exploring the Healthcare Innovator’s 15.57% Potential Upside

For investors with a keen eye on the healthcare sector, CONMED Corporation (NASDAQ: CNMD) presents an intriguing opportunity. With its current market cap standing at $1.3..

Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Unraveling Its 22.8% Potential Upside

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a trailblazer in the biotechnology sector, is capturing the attention of investors with its promising prospects and substantial potential upside. With..

Phreesia, Inc. (PHR) Stock Analysis: Unveiling a 74% Potential Upside in Health Information Services

Phreesia, Inc. (NYSE: PHR), a prominent player in the healthcare sector, is capturing investor attention with a striking potential upside of 74.20%, according to recent analyst..

Ligand Pharmaceuticals (LGND) Stock Analysis: Strong Buy Ratings and Significant Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a biopharmaceutical company, is rapidly becoming a focal point for investors, boasting a robust market capitalization of $3.78 billion. Known for..

Arcellx, Inc. (ACLX) Stock Analysis: A Biotech Innovator with 81.71% Potential Upside

Arcellx, Inc. (NASDAQ: ACLX), a notable player in the biotechnology sector, is making waves with its innovative approach to immunotherapy. Specializing in treatments for cancer and..

PACS Group, Inc. (PACS) Stock Analysis: Unpacking a 31% Revenue Growth and 11% Potential Upside

PACS Group, Inc. (NASDAQ: PACS), a key player in the healthcare sector, has captured investor interest with its remarkable financial trajectory and robust growth prospects. Operating..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds